SCHEMBL7864005

SCHEMBL7864005

C/C=C(/OC)c1ccc(-c2nccs2)cc1CC

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.43
SMPD3 Q9NY59 1/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.41
TRPM4 Q8TD43 1/20 0.41
LOXL2 Q9Y4K0 1/20 0.39
MAPK14 Q16539 1/20 0.39
SMO Q99835 1/20 0.39
KCNB1 Q14721 4/20 0.39
KCNA5 P22460 1/20 0.39
HDAC2 Q92769 1/20 0.38
FFAR1 O14842 1/20 0.38
TACR1 P25103 1/20 0.37
ABL1 P00519 1/20 0.37
BCR P11274 1/20 0.37
LTA4H P09960 1/20 0.37
HSD17B1 P14061 1/20 0.37
LRRK2 Q5S007 1/20 0.36
PORCN Q9H237 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3712445 0.86 PTGDR2 (0.44) ADRB2SMPD3PTGDR2TRPM4LOXL2
SCHEMBL3712377 0.81 TRPM4 (0.48) ADRB2PTGDR2TRPM4LOXL2HDAC2
SCHEMBL7907897 0.72 MAPK14 (0.45) ADRB2SMPD3PTGDR2TRPM4MAPK14
Ethoxycarbonyl Group SCHEMBL29291640 0.68 ADRB2 (0.47) ADRB2SMPD3PTGDR2LOXL2HDAC2
SCHEMBL8240124 0.67 LOXL2 (0.67) ADRB2SMPD3LOXL2ABL1BCR
SCHEMBL13728050 0.67 LOXL2 (0.57) ADRB2PTGDR2LOXL2HDAC2FFAR1
SCHEMBL3722096 0.67 TRPM4 (0.47) ADRB2PTGDR2TRPM4LOXL2MAPK14
SCHEMBL8232408 0.67 CHEK2 (0.47) ADRB2PTGDR2LOXL2HDAC2LRRK2
SCHEMBL25735777 0.67 LOXL2 (0.61) ADRB2SMPD3PTGDR2LOXL2FFAR1
SCHEMBL27666818 0.66 EGFR (0.51) ADRB2SMPD3PTGDR2LOXL2KCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118208-A1 BENZOXAZEPIN-4- (5H) -YL DERIVATIVES AND THEIR USE TO TREAT CANCER EXELIXIS, INC. (US) 2010-10-14 WO disclosed